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Abstract The diagnosis of anti-Hu-associated encepha-
lomyelitis/sensory neuropathy may be particularly difficult
when cranial nerve involvement represents the first clinical
manifestation of the disease. We report a case of a patient
who presented with facial pain as the first manifestation of
an anti-Hu paraneoplastic syndrome, which needs a rapid
detection and treatment of the underlying tumour. We
suggest that paraneoplastic neuropathy should be consid-
ered during the management of trigeminal neuropathic
pain, especially when brain imagery is normal.
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Introduction
Management of facial pain can be difficult regarding
aetiology diagnosis. Trigeminal neuropathic pain requires
specialised investigations to exclude a structural lesion
involving the fifth cranial nerve in its full course, from its
nuclei in the brainstem to its peripheral branches. If this
investigation is normal, screening laboratory tests must be
considered to exclude a neuropathy caused by infectious
agents or connective tissue diseases and vasculitis. Rare
causes of sensory neuropathy may also be considered such
as paraneoplastic neuropathy, which needs a rapid detec-
tion and treatment of the tumour. We report a case of a
patient who presented with trigeminal neuropathic pain as
the first manifestation of an anti-Hu-associated brainstem
encephalitis.
Case report
A non smoker 74-year-old woman presented with left
facial pain of 2-month duration. She complained from an
intermittent burning sensation located in the second divi-
sion of the left trigeminal nerve (V2) and reported cheek
numbness. Sensory stimulation of the face did not pre-
cipitate facial pain. The patient also reported a 1-month
history of asthenia and diarrhoea. The first patient’s gen-
eral examination disclosed normal findings including
normal facial sensitivity. There was no palpable regional
lymph node. The oro-facial examination was normal. No
abnormality was detectable on repeated brain MRI with
gadolinium.
After 3 months, the patient reported dry mouth and dry
eyes confirmed by a Shirmer’s test. Neurological exami-
nation revealed hypoesthesia in the left maxillary branch.
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Blink reflex was normal. Electromyography and nerve
conduction tests were not conducted because the patient
had no clinical symptom of peripheral neuropathy. Clo-
nazepam and pregabaline treatments were administrated
without pain relief. The brain MRI remained normal. Blood
tests showed elevated erythrocyte sedimentation rate (ESR)
(44 for a normal \20) but normal C-reactive protein.
Glycosylated hemoglobin and liver function tests were
normal. Immunologic tests showed negative anti-Ro/
anti-SS-A, anti-SS-B antibodies, antinuclear antibody,
anti-neutrophil cytoplasmic antibodies (ANCAs). Serum
angiotensin-converting enzyme was normal. Temporal
artery biopsy did not reveal giant cell arteritis. Labial sal-
ivary gland biopsy for Sjo¨gren’s syndrome was negative. A
broad serological screening for infectious conditions
including HIV, herpes simplex virus 1 and 2, hepatitis,
Lyme and syphilis was negative. The cerebrospinal fluid
(CSF) analysis showed oligoclonal bands with normal
protein levels. No malignant cells were disclosed. Anti-Hu
antibodies were detected in the serum with dot blot and
indirect immunofluorescence techniques [1].
To localise the suspected malignancy, the patient
underwent computed tomography (CT) scans of the chest
and abdomen which disclosed an axillary lymph node
(Fig. 1) and retroperitoneal lymph nodes. The results of the
mammography, gastroscopy, coloscopy, bone marrow
biopsy were normal. The whole body PET/CT scan dem-
onstrated increased uptake of 18-F-FDG in the axillary and
retroperitoneal lymph nodes, but disclosed no primitive
tumour. The biopsy of the axillary lymph node diagnosed a
small cell lung carcinoma. We concluded to the diagnosis
of anti-Hu trigeminal neuropathy as a first manifestation of
paraneoplastic brainstem encephalitis and suggested that
the diarrhoea, dry month and dry eyes were due to para-
neoplastic dysautonomia. A chemotherapy treatment with a
combination of cisplatin and etoposide was administrated.
The outcome was rapidly unfavourable. After 2 months,
the patient developed dysarthria and dysphagia. The chest
CT scan showed an increased size of the axillary lymph
node. A second-line chemotherapy was introduced without
success. The patient died 14 months after the first signs of
trigeminal numbness.
Discussion
Trigeminal nerve involvement is a frequent cause of facial
pain. In our patient, cheek numbness and further trigeminal
hypoesthesia strongly suggested symptomatic trigeminal
neuropathy. A structural lesion involving the fifth cranial
nerve was excluded by the normality of the brain MRI.
Vasculitis and connective tissue diseases associated
with trigeminal neuropathy were then considered. The
association of xerophthalmia and xerostomia suggested a
Sjo¨gren’s syndrome, which is associated with a sensory
trigeminal involvement in 16% [2]. However, the absence
of anti-Ro/anti-SS-A, anti-SS-B antibodies and the nor-
mality of the labial salivary gland biopsy argued against
this diagnosis. Trigeminal neuropathy has been also
reported in association with other connective tissue dis-
eases, such as scleroderma or mixed connective tissue
diseases [3], but the lack of joint, renal, eye, skin
involvement, and the normality of the immunologic tests
prompted us to reject these diagnoses. There was no evi-
dence of infection on serological screening.
Facial pain as a first manifestation of a cancer was also
considered. Trigeminal neuropathic pain can be associated
with cancer, either by a direct compression of the nuclei in
the brainstem or of the peripheral branches by the tumour
or by a meningeal carcinomatosis. In our patient, we did
not disclose any evidence of metastatic invasion nor con-
tiguity spread of a tumour lesion to the trigeminal nerve.
Conversely, the CSF oligoclonal bands and the detection of
anti-Hu antibody confirmed the hypothesis of a paraneo-
plastic syndrome.
Cranial nerve involvement represents one of the mani-
festations of anti-Hu-associated brainstem encephalitis [4]
which is associated with a small-cell lung carcinoma in the
majority of patients. Brainstem symptoms can be isolated
or associated during paraneoplastic encephalomyelitis with
signs of widespread dysfunction of the nervous system [1,
5, 6]. The frequency of trigeminal involvement in patients
with anti-Hu antibodies is unknown. Facial numbness was
described in 2 out of 23 patients with brainstem encepha-
litis reported by Dalmau et al [6]. Trigeminal involvement
can emerged early in the course of paraneoplastic syn-
drome with anti-Hu antibodies in association with multiple
cranial nerve palsies [7] or with progressive dysautonomia
[8]. To our knowledge, only one previous study has
reported trigeminal involvement as the first manifestation
of an anti-Hu neuropathy [9]. However, we suggest that
Fig. 1 Left axillary lymph node revealed by the chest CT scan
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trigeminal paraneoplastic involvement may be underesti-
mated. 33 cases of facial pain as the first manifestation of
lung cancers have been collected in literature in 2003 [10].
In these patients, the mean delay between the onset of
facial pain and the diagnosis of lung cancer was 9 months.
In most cases, the pain was described as severe and aching
and commonly affected the jaws and temporal region.
In two patients, the diagnosis of trigeminal neuralgia was
previously made. Several mechanisms were proposed to
explain facial pain, such as local invasion, compression of
the nerve or a paraneoplastic syndrome. To our knowledge,
screening for paraneoplastic antibodies was not performed
in these studies.
In conclusion, trigeminal neuropathy is a well-known
symptom occurring during the evolution of patients with
anti-Hu-associated encephalomyelitis/sensory neuropathy,
but can also represent the first isolated manifestation of a
paraneoplastic syndrome.
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